Inventor · San Diego, CA, US

Alan P. Kaplan

30Patents
3h-index
30Co-inventors
59Inventor score

Filing activity: Feb 27, 2007 → May 28, 2019

Most-cited inventions

PatentTitleAreaCited byStatus
US7829713B2 Therapeutic piperazines Chemistry; Metallurgy 37 Active
US8338405B2 Therapeutic piperazines Chemistry; Metallurgy 5 Active
US8222243B2 Therapeutic isoxazole compounds Chemistry; Metallurgy 5 Active
US7872002B2 Therapeutic pyrazoloquinoline derivatives Human Necessities 3 Active
US7919626B2 Pyrazole compounds and uses thereof Chemistry; Metallurgy 3 Active
US9708334B2 Substituted 2,4,5,6-tetrahydropyrrolo[3,4-c]pyrazole and 4,5,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridine compounds as GlyT1 inhibitors Chemistry; Metallurgy 2 Active
US9120770B2 Substituted pyridine and pyrazine compounds as PDE4 inhibitors Chemistry; Metallurgy 2 Active
US9102674B2 Substituted naphthyridine and quinoline compounds as MAO inhibitors Chemistry; Metallurgy 2 Active
US9150572B2 Substituted naphthyridine and quinoline compounds as MAO inhibitors Chemistry; Metallurgy 2 Active
US9650349B2 Therapeutic isoxazole compounds Chemistry; Metallurgy 2 Active
US9675605B2 Substituted naphthyridine and quinoline compounds as MAO inhibitors Chemistry; Metallurgy 1 Active
US8921399B2 Therapeutic isoxazole compounds Chemistry; Metallurgy 1 Active
US8791137B2 Therapeutic compounds Chemistry; Metallurgy 1 Active
US9029397B2 Therapeutic isoxazole compounds Chemistry; Metallurgy 1 Active
US7863266B2 Therapeutic pyrazoloquinoline urea derivatives Human Necessities 1 Active
US9573937B2 Substituted pyridine and pyrazine compounds as PDE4 inhibitors Chemistry; Metallurgy 1 Active
US7858614B2 Therapeutic pyrazolonaphthyridine derivatives Human Necessities 1 Active
US9040692B2 Substituted pyridine and pyrazine compounds as PDE4 inhibitors Chemistry; Metallurgy 1 Active
US8277842B1 Enteric-coated HT-2157 compositions and methods of their use Human Necessities 1 Active
US8399487B2 Pyrazole compounds and uses thereof Chemistry; Metallurgy 0 Active
US9956213B2 Substituted naphthyridine and quinoline compounds as MAO inhibitors Chemistry; Metallurgy 0 Active
US8598159B2 Therapeutic pyrazoloquinoline derivatives Human Necessities 0 Active
US10053467B2 Therapeutic isoxazole compounds Chemistry; Metallurgy 0 Active
US8501745B2 Piperazine PDE4 inhibitors and uses thereof Chemistry; Metallurgy 0 Active
US8497262B2 Therapeutic pyrazolonaphthyridine derivatives Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.